Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

RNC Pharma: 2023 Retails Sales of Russian-Made Enteral Nutrition Up 69%

Friday, February 9, 2024

In 2023, the sales of enteral nutrition on the Russian retail market (e-com included) were 4.8 billion rubles (retail prices, VAT included), or 12.4 million packages. The sales went up 12.2% in monetary terms, but went down 1.9% in physical terms, which is a clear indicator that the market was able to grow last year only because of inflation.

The active development of marketplaces led to serious structural changes. While the online sales of enteral nutrition in 2023 went up by 56.5% in monetary terms and by 41% in physical terms, the offline sales fell 9% in packages and grew by only 1.9% in rubles. As a result, the share of the online segment grew by 7.4% in monetary terms, reaching 26.3%, and by 6.2% in physical terms, reaching 20.4%.

The offline sales differed from region to region; in particular, the largest volume was sold in the Central Federal District—3.11 million packages worth around 1.22 billion rubles, which is about a third of the total sales. Half as much enteral nutrition was sold in the Volga Federal District; the Northwestern Federal District closes the top three. The highest retail price, 392 rubles, was found in both the Central Federal District and Northwestern Federal District. A comparable price, 390 rubles, was found in the North Caucasus. Finally, you could buy the cheapest package of enteral nutrition in the Urals—for 306 rubles. Interestingly, the most expensive products are sold online—for nearly 500 rubles per package.

In 2023, 32 brands of enteral nutrition were sold on the retail market, 1 brand up from 2022. The new brand included was Seneopro Visco Clear Dysphagia, which, as the name suggests, is used for swallowing disorders. The number of SKUs on the market was 265, up 10 from 2022. Abbott Pediasure was the most sold product in monetary terms, accounting for almost 33% of the sales (online sales included). At the same time, its sales in 2023 grew by only 4% from 2022. Nutilis by Nutricia (a division of Danone), a product for dysphagia, had the best growth rates—its sales increased 68 times against 2022. In terms of turnover though, this product is still considered niche. The sales of Leovit products by Russian Leovit Nutrio went up 3.7 times against 2022; protein shakes for patients with cancer contributed to the growth rates the most. Among the 10 products with the largest sales volumes in monetary terms, the sales of Fresubin by German Fresenius grew 67%, and the sales of Nutrien by Russian Infaprim went up 57%. Both brands include dozens of SKUs, and most of them showed significant growth.

Fig. Retail sales of enteral nutrition in Russian federal districts in 2023